Nucleic Acid Delivery Controlling System and Method for Manufacturing Same, and Nucleic Acid Sequencing Device
The present invention provides: a nucleic acid delivery controlling system in which a novel delay principle is utilized to greatly delay the nanopore passing rate of a nucleic acid strand, thereby enabling the stable analysis of a nucleotide sequence; a method for manufacturing the nucleic acid delivery controlling system; and a nucleic acid sequencing device. The present invention relates to a nucleic acid delivery controlling system, equipped with a passage through which a nucleic acid strand can pass, said nucleic acid delivery controlling system being characterized in that the passage through which a nucleic acid strand can pass has at least one nanochannel having multiple passages per one nanopore through which only one molecule of the nucleic acid strand can pass, the nanochannel has a microphase-separated structure composed of a block copolymer that is composed of a hydrophobic polymer chain and a hydrophilic polymer chain, and the nanochannel contains the hydrophilic polymer chain of the block copolymer as the main component.
1 . A nucleic acid transport controlling device comprising a nucleic acid strand translocation pathway,
wherein the nucleic acid strand translocation pathway includes one or more multipath Nano channels per nanopore that allows passage of only one molecule of nucleic acid strand,
wherein the Nano channels have a microphase-separated structure of a block copolymer of a hydrophobic polymer chain and a hydrophilic polymer chain, and
wherein the Nano channels contain the hydrophilic polymer chain of the block copolymer as a main component.
2 . The nucleic acid transport controlling device according to claim 1 , wherein the nucleic acid strand translocation pathway includes a single multipath nanochannel per nanopore that allows passage of only one molecule of nucleic acid strand.
3 . The nucleic acid transport controlling device according to claim 1 , wherein the nanopore and the nanochannels are disposed in contact with each other, or by being separated from each other.
4 . The nucleic acid transport controlling device according to claim 1 , further comprising:
an insulating base material; and
a thin membrane directly or indirectly disposed above the insulating base material and containing the block copolymer,
wherein the insulating base material includes the nanopore, and
wherein the thin membrane includes the Nano channels, and a matrix disposed around the Nano channels.
5 . The nucleic acid transport controlling device according to claim 1 , wherein the nanochannels have a branched structure.
6 . The nucleic acid transport controlling device according to claim 1 , wherein the nanochannels and the matrix have a co-continuous structure.
7 . The nucleic acid transport controlling device according to claim 3 , wherein the nanopore and the nanochannels are disposed by being separated from each other, and wherein the nanochannels have a cylindrical structure.
8 . The nucleic acid transport controlling device according to claim 1 , wherein the hydrophilic polymer chain includes polyethylene oxide, polylactic acid, polyhydroxyalkylmethacrylate, polyacrylamide, polyacrylic acid, a polyamino acid, or a nucleic acid.
9 . The nucleic acid transport controlling device according to claim 1 , wherein the hydrophobic polymer chain has a liquid-crystalline side chain.
10 . The nucleic acid transport controlling device according to claim 9 , wherein the hydrophobic polymer chain has a structure in which the alkyl moiety of the polyalkylmethacrylateis partially or completely substituted with theliquid-crystallinechain.
11 . A nucleic acid transport controlling device comprising a nucleic acid strand translocation pathway,
wherein the nucleic acid strand translocation pathway includes one or more multipath Nano channels per nanopore that allows passage of only one molecule of nucleic acid strand,
wherein the nucleic acid transport controlling device includes an insulating base material having one or more of the nanopore, and a thin membrane directly or indirectly disposed above the insulating base material,
wherein the thin membrane includes one or more of the nanochannels, and a matrix disposed around the Nano channels, and
wherein the nanochannels are packed with a hydrophilic polymer chain immobilized at the interface between the nanochannels and the matrix.
12 . A method for manufacturing a nucleic acid transport controlling device that includes a nucleic acid strand translocation pathway that includes one or more multipath Nano channels per nanopore that allows passage of only one molecule of nucleic acid strand,
the method comprising the steps of:
forming the nanopore in the insulating base material;
forming a thin membrane of a block copolymer of a hydrophobic polymer chain and a hydrophilic polymer chain above the insulating base material; and
causing the block copolymer to self-assemble, and form a Nano channel having a microphase-separated structure of the block copolymer and containing the hydrophilic polymer chain as a main component.
13 . The method according to claim 12 , wherein the step of forming the nanopore is performed after the step of forming the Nano channel.
14 . A nucleic acid sequencing apparatus comprising:
the nucleic acid transport controlling device of claim 1 ;
two solution cells that are in communication with each other via the nucleic acid strand translocation pathway of the nucleic acid transport controlling device; and
an electrode provided for each of the two solution cells to apply a voltage between the solution cells.
15 . The nucleic acid sequencing apparatus according to claim 14 , wherein the nucleic acid transport controlling device has a plurality of nucleic acid strand translocation pathways that are disposed parallel to each other.
16 . The nucleic acid sequencing apparatus according to 14 , further comprising a device for measuring a time-course change of a current amount passed between the electrodes.